The Hyperthermic Intraperitoneal Chemotherapy; Indication, Techniques and Complications; A Systematic Review of the Current Literature

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 417

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

SISOC01_044

تاریخ نمایه سازی: 3 اردیبهشت 1398

چکیده مقاله:

BACKGROUND: The combination of cytoreductive surgery and preoperative adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) have been demonstrated to be associated with improved the outcome of patients with intraperitoneal malignancies especially the gynecologic cancers. The aim of the current review is to provide a comprehensive overview of the indications, techniques and complications of HIPEC in a variety of intraperitoneal malignancies. METHODS: This is a systematic review of the current literature published on the issue. We search the electronic databases including Medline, Scopus, CINAHEL, Embase and Scholar using the appropriate keywords. All the appropriate article between 2000 and 2018 were retrieved and evaluated for eligibility. The data were extracted and assessed using a database. The results were provided to cover the issues completely. RESULTS: We overall Several methods of delivering hyperthermic intraperitoneal chemotherapy (HIPEC) have been described, but no significant differences in treatment outcomes, morbidity, or safety have been found among them, and the ultimate choice between them is left to individual preference or institutional criteria. These methods include the open, closed and mixed methods. Administration of HIPEC is safe for the personnel working in the operating room; chemotherapy exposure during the procedure is negligible provided universal precautions, individual protection measures, and environmental safety guidelines are followed. Proper education of operating room staff about the essentials of HIPEC and proper chemotherapy handling is the first safety requirement. CONCLUSION: HIPEP is a considered a safe treatment option for patients with intraperitoneal malignancies especially the ovarian cancer being associated with increased gross total resection, decreased mortality and increased survival when followed by cytoreduction surgery. the knowledge of the current advancements is required for an oncologic surgeon.

نویسندگان

Maryam Dehghankhalili

Student Research Committee, Department of Surgery, Shiraz University of Medical Sciences

Vahid Zangouri

Breast Diseases Research Center, Shiraz University of Medical Sciences

Abtin Vahidi

Student Research Committee, Department of Surgery, Shiraz University of Medical Sciences

Majid Akrami

Student Research Committee, Department of Surgery, Shiraz University of Medical Sciences